MR spectroscopy in amyotrophic lateral sclerosis/motor neuron disease

Journal of the Neurological Sciences

Volumn 152, Issue SUPPL. 1, 1997, Pages

  Pioro, Erik P ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Brain; Cortex; Creatine; Echo time; Glutamate; Motor neuron degeneration; N Acetyl aspartate; Proton MRSI

Indexed keywords

CHOLINE; CREATINE; CREATINE PHOSPHATE; GLUTAMIC ACID; GLUTAMINE; N ACETYLASPARTIC ACID;

AMYOTROPHIC LATERAL SCLEROSIS; BRAIN STEM; CONFERENCE PAPER; MOTOR NEURON DISEASE; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTON NUCLEAR MAGNETIC RESONANCE; SENSORIMOTOR CORTEX;

AMYOTROPHIC LATERAL SCLEROSIS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MOTOR NEURON DISEASE;

EID: 0030656472     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)00244-X     Document Type: Conference Paper

References (31)

1. Arnold D.L., Matthews P.M., Francis G.S., O'Connor J., Antel J.P. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann. Neurol. 31:1992;235-241.
2. 1H-NMR spectroscopic studies of brain. Neurosci. Behav. Rev. 13:1989;23-31.
3. Castillo M., Kwock L., Mukherji S.K. Clinical applications of proton MR spectroscopy. Am. J. Neuroradiol. 17:1996;1-15.
4. Duijn J.H., Matson G.B., Maudsley A.A., Hugg J.W., Weiner M.W. Proton magnetic spectroscopic imaging of human brain infarction. Radiology. 183:1992;711-718.
5. El Escorial World Federation, El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J. Neurol. Sci. 124(Suppl.):1994;96-107.
6. Giroud M., Walker P., Bernard D., Lemesle M., Martin D., Baudouin N., Brunotte F., Dumas R. Reduced brain N-acetyl-aspartate in frontal lobes suggests neuronal loss in patients with amyotrophic lateral sclerosis. Neurol. Res. 18:1996;241-243.
7. Graham G.D., Blamire A.M., Howseman A.M., Rothman D.L., Fayad P.B., Brass L.M., Petroff O.A., Shulman R.G., Prichard J.W. Proton magnetic resonance spectrosocopy of cerebral lactate and other metabolites in stroke patients. Stroke. 23:1992;333-340.
8. Graham S.H., Meyerhoff D.J., Bayne L., Sharp F.R., Weiner M.W. Magnetic resonance spectroscopy of N-acetylaspartate in hypoxic-ischemic encephalopathy. Ann. Neurol. 35:1994;490-494.
9. Gredal O., Rosenbaum S., Topp S., Karlsborg M., Strange P., Werdelin L. Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy. Neurology. 48:1997;878-881.
10. Jones A.P., Gunawardena W.J., Coutinho C.M.A., Gatt J.A., Shaw I.A., Mitchell J.D. Preliminary results of proton magnetic resonance spectroscopy in motor neurone disease (amyotrophic lateral sclerosis). J. Neurol. Sci. 129(Suppl.):1995;85-89.
11. Koller K.J., Zaczek R., Coyle J.T. N-Acetyl-aspartyl-glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method. J. Neurochem. 43:1984;1136-1142.
12. Majors A., Xue M., Ng T.C., Modic M.T. Short echo time proton spectroscopy of human brain using a gradient head coil. Mag. Res. Imaging. 10:1992;649-654.
13. Marsh L., Lim K.O., Sullivan E.V., Lane B., Spielman D. Proton magnetic resonance spectroscopy of a gray matter heterotopia. Neurology. 47:1996;1571-1574.
14. 1H-MRS of brain. Mag. Res. Imaging. 14:1996;281-292.
15. Masaharu M., Kakimoto Y., Sorimachi M. A gas chromatographic method method for the determination of N-acetyl-L-aspartic acid, N-acetyl-aspartylglutamic acid and citryl-L-glutamic acid and their distributions in the brain and other organs of various species of animals. J. Neurochem. 36:1981;804-810.
16. 1H magnetic resonance spectroscopic imaging. Neurology. 43:1993;509-515.
17. Meyerhoff D.J., MacKay S., Constans J.-M., Norman D., Van Dyke C., Fein G., Weiner M.W. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Ann. Neurol. 36:1994;40-47.
18. 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed. 4:1991;47-52.
19. Moffett J.R., Namboodiri M.A., Cangro C.B., Neale J.H. Immunohistochemical localization of N-acetylaspartate in rat brain. Neuroreport. 2:1991;131-134.
20. Ng T.C., Comair Y., Xue M., So N., Majors A., Kolem H., Lüders H.O., Modic M.T. Temporal lobe epilepsy: Presurgical localization with proton chemical shift imaging. Radiology. 193:1994;465-472.
21. Pioro E.P., Antel J.P., Cashman N.R., Arnold D.L. Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology. 44:1994;1933-1938.
22. Provencher S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn. Reson. Med. 30:1993;672-679.
23. Rothstein J.D. Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis. Adv. Neurol. 68:1995;7-20.
24. Russell J.R., DeMyer W. The quantitative cortical origin of pyramidal axons of Macaca rhesus. Neurology. 11:1961;96-108.
25. Schiffmann R., Moller J.R., Trapp B.D., Shih H.H., Farrer R.G., Katz D.A., Alger J.R., Parker C.C., Hauer P.E., Kaneski C.R., Heiss J.D., Kaye E.M., Quarles R.H., Brady R.O., Barton N.W. Childhood ataxia with diffuse central nervous system hypomyelination. Ann. Neurol. 35:1994;331-340.
26. Simmons M.L., Frondoza C.G., Coyle J.T. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience. 45:1991;37-45.
27. Tedeschi G., Bertolino A., Massaquoi S.G., Campbell G., Patronas N.J., Bonavita S., Barnett A.S., Alger J.R., Hallett M. Proton magnetic resonance spectroscopic imaging in patients with cerebellar degeneration. Ann. Neurol. 39:1996;71-78.
28. Tzika A.A., Vigneron D.B., Ball W.S. Jr., Dunn R.S., Kirks D.R. Localized proton MR spectroscopy of the brain in children. J Magn. Res. Imaging. 3:1993;719-729.
29. Urenjak J., Williams S.R., Gadian D.G., Noble M. Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 progenitors, and immature oligodendrocytes in vitro. J Neurochem. 59:1992;55-61.
30. Vion-Dury J., Meyerhoff D.J., Cozzone P.J., Weiner M.W. What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy? J. Neurol. 241:1994;354-371.
31. Younger D.S., Rowland L.P., Latov N., Sherman W., Pesce M., Lange D.J., Trojaborg W., Miller J.R., Lovelace R.E., Hays A.P., Kim T.S. Motor neuron disease and amyotrophic lateral sclerosis: Relation of high CSF protein content to paraproteinemia and clinical syndromes. Neurology. 40:1990;595-599.